{"authors": [["Gosch", "M", "M", "Medizinische Klinik 2 - Schwerpunkt Geriatrie, Universit\u00e4tsklinik f\u00fcr Geriatrie, Klinikum N\u00fcrnberg, Paracelsus Medizinische Privatuniversit\u00e4t, Campus N\u00fcrnberg, Prof.-Ernst-Nathan-Str.\u00a01, 90419, N\u00fcrnberg, Deutschland. markus.gosch@klinikum-nuernberg.de."], ["Wicklein", "S", "S", "Medizinische Klinik 2 - Schwerpunkt Geriatrie, Universit\u00e4tsklinik f\u00fcr Geriatrie, Klinikum N\u00fcrnberg, Paracelsus Medizinische Privatuniversit\u00e4t, Campus N\u00fcrnberg, Prof.-Ernst-Nathan-Str.\u00a01, 90419, N\u00fcrnberg, Deutschland."]], "doi": "10.1007/s00391-017-1352-x", "date": "2018-01-16_23:18:33", "journal": ["Zeitschrift fur Gerontologie und Geriatrie", "Z Gerontol Geriatr"], "year": null, "title": "[Antibodies as treatment option in older adults].", "id": "29264687", "text": ["monoclonal", "antibodies", "already", "used", "many", "different", "clinical", "indications", "besides", "oncology", "rheumatology", "denosumab", "antibody", "currently", "prescribed", "older", "adults", "osteoporosis", "however", "apart", "osteoporosis", "might", "possible", "indications", "use", "antibodies", "chronic", "diseases", "geriatric", "syndromes", "particularly", "respect", "sarcopenia", "transition", "doping", "older", "adults", "seems", "fluent", "present", "review", "provides", "overview", "newest", "developments", "prospective", "options"]}